Pendapatan operasional sadurunge ngurangi amortisasi: Longeveron (LGVN)

Logo grafis longeveron.com (LGVN)

The regenerative medicine sector currently relies on the test results of Lomecel-B against Alzheimer's disease. Longeveron Inc. (LGVN) is expanding its capacities in Florida, minimizing reliance on third-party laboratories during drug development. Actual EBITDA demonstrates the business's liquidity vector, where the 0.00 level indicates the state of the parameter. This chart smooths out market noise, helping investors determine the real cash flow.

LGVN (Longeveron) riwayat Bathi sadurunge mbayar bunga, pajak, lan amortisasi saka 23.11.2025 nganti 12.11.2026

Longeveron (LGVN) - rincian metrik lan laporan keuangan

- rega saham lan target rega konsensus:
Bagan rega Longeveron Corporation|LGVN - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Kapitalisasi pasar Longeveron|LGVN - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Aset Bersih saben Siji Saham Longeveron|LGVN - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku longeveron.com|LGVN - Aset Agregat Perusahaan
- data tingkat utang lan likuiditas finansial:
Rasio Utang marang Ekuitas Longeveron Inc.|LGVN - Utang jangka dawa marang modal|Tanggungan utang jangka cendhak marang ekuitas Longeveron Inc|LGVN - Gunggung utang perusahaan|Utang-utang marang nilai buku Longeveron|LGVN - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Longeveron|Likuiditas darurat longeveron.com
- indikator pendapatan resik lan kelipatan nilai:
LGVN - Bathi resik perusahaan|Penghasilan resik sing dikarepake Longeveron Inc.|LGVN - Rasio rega marang bathi|Rasio prakiraan rega marang bathi longeveron.com|LGVN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Longeveron|LGVN - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Longeveron|LGVN - Bathi resik saben saham (EPS TTM)|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan longeveron.com|LGVN - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Longeveron Inc.
Ringkesan analitik perusahaan:Longeveron Inc.
Barang unggulan Longeveron

Stable utilization of the Longeveron Inc. (LGVN) biomanufacturing complex, coupled with the uninterrupted operation of sterile zones, directly determines cash flow dynamics. Analyzing EBITDA allows for the daily tracking of real business expansion, eliminating quarterly reporting lags. While growth in this indicator confirms the issuer's fundamental strength, purchasing the asset at a local peak on the chart risks a prolonged price drawdown.

Analisis pesaing Longeveron Inc.

Mesoblast Pharma - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|LCTX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi surrozen.com SRZN|cryo-cell.com (CCEL) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|FBLG (FibroBiologics) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi BioRestorative Therapies Inc|Bathi sadurunge bunga, pajak, lan amortisasi Creative Medical Technology Holdings Inc. CELZ